Amylyx Pharmaceuticals, Inc. (AMLX)
14.90
+0.79
(+5.60%)
USD |
NASDAQ |
Mar 04, 13:21
Amylyx Pharmaceuticals Research and Development Expense (Annual) : 103.18M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Rapt Therapeutics, Inc. | 107.22M |
| Disc Medicine, Inc. | 170.36M |
| Cytokinetics, Inc. | 405.90M |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| MediciNova, Inc. | 7.135M |